Table 2.
Parameter | proNGF | p-Value | |
---|---|---|---|
Negative | Positive | ||
Sex | 0.1562 | ||
Female | 30 (81%) | 7 (19%) | |
Male | 38 (69%) | 17 (31% | |
Age | 0.9151 | ||
≤63 | 37 (79%) | 10 (21%) | |
>63 | 31 (69%) | 14 (31%) | |
Grade | 0.3415 | ||
I–II | 7 (87.5%) | 1 (12.5%) | |
III | 8 (67%) | 4 (33%) | |
GBM | 53 (74%) | 19 (26%) | |
Tumor site | 0.6417 | ||
Frontal | 28 (72%) | 11 (28%) | |
Temporal | 23 (77%) | 7 (23%) | |
Other | 17 (55%) | 6 (45%) |